{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,31]],"date-time":"2026-07-31T02:31:07Z","timestamp":1785465067299,"version":"3.56.0"},"reference-count":39,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2023,9,1]],"date-time":"2023-09-01T00:00:00Z","timestamp":1693526400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,9,1]],"date-time":"2023-09-01T00:00:00Z","timestamp":1693526400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2023,9,1]],"date-time":"2023-09-01T00:00:00Z","timestamp":1693526400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2023,9,1]],"date-time":"2023-09-01T00:00:00Z","timestamp":1693526400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2023,9,1]],"date-time":"2023-09-01T00:00:00Z","timestamp":1693526400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2023,9,1]],"date-time":"2023-09-01T00:00:00Z","timestamp":1693526400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2023,9,1]],"date-time":"2023-09-01T00:00:00Z","timestamp":1693526400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100012236","name":"Beijing Institute of Technology Research Fund Program for Young Scholars","doi-asserted-by":"publisher","award":["XSQD-202213001"],"award-info":[{"award-number":["XSQD-202213001"]}],"id":[{"id":"10.13039\/501100012236","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["31971307"],"award-info":[{"award-number":["31971307"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["32000950"],"award-info":[{"award-number":["32000950"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82002848"],"award-info":[{"award-number":["82002848"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Biochemical Pharmacology"],"published-print":{"date-parts":[[2023,9]]},"DOI":"10.1016\/j.bcp.2023.115699","type":"journal-article","created":{"date-parts":[[2023,7,22]],"date-time":"2023-07-22T02:34:44Z","timestamp":1689993284000},"page":"115699","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":6,"special_numbering":"C","title":["Verification of fasting-mimicking diet to assist monotherapy of human cancer-bearing models"],"prefix":"10.1016","volume":"215","author":[{"given":"Wenping","family":"Huang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaoyang","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Haohao","family":"Song","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yue","family":"Yin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hai","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"1","key":"10.1016\/j.bcp.2023.115699_b0005","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1016\/j.addr.2012.10.002","article-title":"The EPR effect for macromolecular drug delivery to solid tumors: improvement of tumor uptake, lowering of systemic toxicity, and distinct tumor imaging in vivo","volume":"65","author":"Maeda","year":"2013","journal-title":"Adv. Drug Deliv. Rev."},{"issue":"17","key":"10.1016\/j.bcp.2023.115699_b0010","doi-asserted-by":"crossref","first-page":"7921","DOI":"10.7150\/thno.49577","article-title":"The EPR effect and beyond: Strategies to improve tumor targeting and cancer nanomedicine treatment efficacy","volume":"10","author":"Shi","year":"2020","journal-title":"Theranostics."},{"issue":"2","key":"10.1016\/j.bcp.2023.115699_b0015","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1016\/j.jconrel.2012.03.020","article-title":"Doxil\u00ae\u2014The first FDA-approved nano-drug: Lessons learned","volume":"160","author":"Barenholz","year":"2012","journal-title":"J. Control. Release"},{"issue":"2","key":"10.1016\/j.bcp.2023.115699_b0020","doi-asserted-by":"crossref","first-page":"437","DOI":"10.1016\/j.ygyno.2005.09.012","article-title":"Abraxane in the treatment of ovarian cancer: the absence of hypersensitivity reactions","volume":"100","author":"Micha","year":"2006","journal-title":"Gynecol. Oncol."},{"issue":"12","key":"10.1016\/j.bcp.2023.115699_b0025","doi-asserted-by":"crossref","first-page":"1362","DOI":"10.1038\/s41563-020-0755-z","article-title":"The dose threshold for nanoparticle tumour delivery","volume":"19","author":"Ouyang","year":"2020","journal-title":"Nat. Mater."},{"issue":"5","key":"10.1016\/j.bcp.2023.115699_b0030","doi-asserted-by":"crossref","first-page":"1909","DOI":"10.1021\/nl900031y","article-title":"Mediating tumor targeting efficiency of nanoparticles through design","volume":"9","author":"Perrault","year":"2009","journal-title":"Nano Lett."},{"key":"10.1016\/j.bcp.2023.115699_b0035","doi-asserted-by":"crossref","first-page":"1 -","DOI":"10.1038\/natrevmats.2017.34","article-title":"Nanomedicine: design and conquer","volume":"2","author":"Matsiko","year":"2017","journal-title":"Nat. Rev. Mater."},{"issue":"1","key":"10.1016\/j.bcp.2023.115699_b0040","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1111\/nyas.12403","article-title":"Nanomedicines: addressing the scientific and regulatory gap","volume":"1313","author":"Tinkle","year":"2014","journal-title":"Ann. N. Y. Acad. Sci."},{"issue":"6","key":"10.1016\/j.bcp.2023.115699_b0045","doi-asserted-by":"crossref","first-page":"1801868","DOI":"10.1002\/advs.201801868","article-title":"Tumors and their microenvironment dual-targeting chemotherapy with local immune adjuvant therapy for effective antitumor immunity against breast cancer","volume":"6","author":"Deng","year":"2019","journal-title":"Adv. Sci."},{"issue":"2","key":"10.1016\/j.bcp.2023.115699_b0050","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1016\/j.nantod.2010.03.003","article-title":"Targeted nanodelivery of drugs and diagnostics","volume":"5","author":"Phillips","year":"2010","journal-title":"Nano Today"},{"issue":"1","key":"10.1016\/j.bcp.2023.115699_b0055","doi-asserted-by":"crossref","first-page":"100","DOI":"10.1016\/j.jconrel.2006.04.014","article-title":"Toxicity of cationic lipids and cationic polymers in gene delivery","volume":"114","author":"Lv","year":"2006","journal-title":"J. Control. Release"},{"key":"10.1016\/j.bcp.2023.115699_b0060","doi-asserted-by":"crossref","first-page":"164","DOI":"10.1016\/j.jconrel.2020.07.007","article-title":"Delivering the power of nanomedicine to patients today","volume":"326","author":"Germain","year":"2020","journal-title":"J. Control. Release"},{"issue":"3","key":"10.1016\/j.bcp.2023.115699_b0065","doi-asserted-by":"crossref","first-page":"1481","DOI":"10.1021\/acs.nanolett.0c00620","article-title":"Nanomedicine toward 2040","volume":"20","author":"Richardson","year":"2020","journal-title":"Nano Lett."},{"key":"10.1016\/j.bcp.2023.115699_b0070","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s12645-017-0030-4","article-title":"Cancer resistance to treatment and antiresistance tools offered by multimodal multifunctional nanoparticles","volume":"8","author":"Casals","year":"2017","journal-title":"Cancer Nanotechnol."},{"issue":"13-14","key":"10.1016\/j.bcp.2023.115699_b0075","doi-asserted-by":"crossref","first-page":"1866","DOI":"10.1016\/j.addr.2013.09.019","article-title":"Nanomedicine therapeutic approaches to overcome cancer drug resistance","volume":"65","author":"Markman","year":"2013","journal-title":"Adv. Drug Deliv. Rev."},{"issue":"1","key":"10.1016\/j.bcp.2023.115699_b0080","article-title":"Carbon nano-onion-mediated dual targeting of P-selectin and P-glycoprotein to overcome cancer drug resistance","volume":"12","author":"Wang","year":"2021","journal-title":"Nat. Commun."},{"issue":"1","key":"10.1016\/j.bcp.2023.115699_b0085","doi-asserted-by":"crossref","DOI":"10.1038\/s41467-021-23071-6","article-title":"Mitochondrial ATP fuels ABC transporter-mediated drug efflux in cancer chemoresistance","volume":"12","author":"Giddings","year":"2021","journal-title":"Nat. Commun."},{"issue":"1","key":"10.1016\/j.bcp.2023.115699_b0090","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1038\/nm.4247","article-title":"Loss of the histone methyltransferase EZH2 induces resistance to multiple drugs in acute myeloid leukemia","volume":"23","author":"G\u00f6llner","year":"2017","journal-title":"Nat. Med."},{"issue":"1","key":"10.1016\/j.bcp.2023.115699_b0095","article-title":"Combining PARP with ATR inhibition overcomes PARP inhibitor and platinum resistance in ovarian cancer models","volume":"11","author":"Kim","year":"2020","journal-title":"Nat. Commun."},{"issue":"30","key":"10.1016\/j.bcp.2023.115699_b0100","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1093\/oxfordjournals.jncimonographs.a003451","article-title":"Side effects of chemotherapy and combined chemohormonal therapy in women with early-stage breast cancer","volume":"2001","author":"Partridge","year":"2001","journal-title":"JNCI Monographs."},{"issue":"23","key":"10.1016\/j.bcp.2023.115699_b0105","doi-asserted-by":"crossref","first-page":"38022","DOI":"10.18632\/oncotarget.16723","article-title":"Combination therapy in combating cancer","volume":"8","author":"Mokhtari","year":"2017","journal-title":"Oncotarget."},{"issue":"4","key":"10.1016\/j.bcp.2023.115699_b0110","doi-asserted-by":"crossref","first-page":"451","DOI":"10.1158\/2326-6066.CIR-19-0282","article-title":"Interferon-induced IDO1 mediates radiation resistance and is a therapeutic target in colorectal cancerIDO1 inhibition synergizes with radiotherapy","volume":"8","author":"Chen","year":"2020","journal-title":"Cancer Immunol. Res."},{"issue":"9","key":"10.1016\/j.bcp.2023.115699_b0115","doi-asserted-by":"crossref","first-page":"2382","DOI":"10.1093\/annonc\/mdt212","article-title":"A randomized, double-blind, phase II study of erlotinib with or without sunitinib for the second-line treatment of metastatic non-small-cell lung cancer (NSCLC)","volume":"24","author":"Groen","year":"2013","journal-title":"Ann. Oncol."},{"issue":"1","key":"10.1016\/j.bcp.2023.115699_b0120","doi-asserted-by":"crossref","DOI":"10.1038\/s41467-021-23328-0","article-title":"Drug repurposing screens identify chemical entities for the development of COVID-19 interventions","volume":"12","author":"Bakowski","year":"2021","journal-title":"Nat. Commun."},{"key":"10.1016\/j.bcp.2023.115699_b0125","doi-asserted-by":"crossref","first-page":"3083","DOI":"10.1038\/s41467-020-16138-3","article-title":"Fasting mimicking diet as an adjunct to neoadjuvant chemotherapy for breast cancer in the multicentre randomized phase 2 DIRECT trial","volume":"11","author":"de Groot","year":"2020","journal-title":"Nat. Commun."},{"issue":"124","key":"10.1016\/j.bcp.2023.115699_b0130","doi-asserted-by":"crossref","DOI":"10.1126\/scitranslmed.3003293","article-title":"Fasting cycles retard growth of tumors and sensitize a range of cancer cell types to chemotherapy","volume":"4","author":"Lee","year":"2012","journal-title":"Sci. Transl. Med."},{"issue":"7817","key":"10.1016\/j.bcp.2023.115699_b0135","doi-asserted-by":"crossref","first-page":"620","DOI":"10.1038\/s41586-020-2502-7","article-title":"Fasting-mimicking diet and hormone therapy induce breast cancer regression","volume":"583","author":"Caffa","year":"2020","journal-title":"Nature"},{"issue":"6","key":"10.1016\/j.bcp.2023.115699_b0140","first-page":"527","article-title":"Intermittent fasting in the prevention and treatment of cancer","volume":"71","author":"Clifton","year":"2021","journal-title":"CA Cancer J. Clin."},{"issue":"1","key":"10.1016\/j.bcp.2023.115699_b0145","doi-asserted-by":"crossref","DOI":"10.1186\/s12885-016-2370-6","article-title":"Safety and feasibility of fasting in combination with platinum-based chemotherapy","volume":"16","author":"Dorff","year":"2016","journal-title":"BMC Cancer"},{"issue":"14","key":"10.1016\/j.bcp.2023.115699_b0150","doi-asserted-by":"crossref","first-page":"2333","DOI":"10.1080\/15384101.2015.1044170","article-title":"Fasting protects against the side effects of irinotecan but preserves its anti-tumor effect in Apc15lox mutant mice","volume":"14","author":"Huisman","year":"2015","journal-title":"Cell Cycle"},{"issue":"5706","key":"10.1016\/j.bcp.2023.115699_b0155","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1126\/science.1104819","article-title":"Normalization of tumor vasculature: an emerging concept in antiangiogenic therapy","volume":"307","author":"Jain","year":"2005","journal-title":"Science"},{"issue":"26","key":"10.1016\/j.bcp.2023.115699_b0160","doi-asserted-by":"crossref","first-page":"14608","DOI":"10.1073\/pnas.97.26.14608","article-title":"Mosaic blood vessels in tumors: frequency of cancer cells in contact with flowing blood","volume":"97","author":"Chang","year":"2000","journal-title":"Proc. Natl. Acad. Sci."},{"key":"10.1016\/j.bcp.2023.115699_b0165","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1155\/2020\/3576030","article-title":"Fasting therapy contributes to the improvement of endothelial function and decline in vascular injury-related markers in overweight and obese individuals via activating autophagy of endothelial progenitor cells","volume":"2020","author":"Sun","year":"2020","journal-title":"Evid. Based Complement. Alternat. Med."},{"issue":"8","key":"10.1016\/j.bcp.2023.115699_b0170","doi-asserted-by":"crossref","first-page":"3779","DOI":"10.7150\/thno.44115","article-title":"Fasting before or after wound injury accelerates wound healing through the activation of pro-angiogenic SMOC1 and SCG2","volume":"10","author":"Luo","year":"2020","journal-title":"Theranostics."},{"key":"10.1016\/j.bcp.2023.115699_b0175","article-title":"Short-term fasting and fasting mimicking diets combined with chemotherapy: a narrative review","volume":"15","author":"Kikomeko","year":"2023","journal-title":"Therap. Adv. Med. Oncol."},{"issue":"8","key":"10.1016\/j.bcp.2023.115699_b0180","doi-asserted-by":"crossref","DOI":"10.1016\/j.celrep.2022.111256","article-title":"Fasting renders immunotherapy effective against low-immunogenic breast cancer while reducing side effects","volume":"40","author":"Cortellino","year":"2022","journal-title":"Cell Rep."},{"key":"10.1016\/j.bcp.2023.115699_b0185","first-page":"7","article-title":"Bioequivalence study of pegylated doxorubicin hydrochloride liposome (PEGADRIA) and DOXIL\u00ae in ovarian cancer patients: physicochemical characterization and pre-clinical studies","author":"Ali","year":"2016","journal-title":"J. Nanomed. Nanotechnol."},{"issue":"6","key":"10.1016\/j.bcp.2023.115699_b0190","first-page":"708","article-title":"Paclitaxel and curcumin co-bound albumin nanoparticles having antitumor potential to pancreatic cancer","volume":"11","author":"Kim","year":"2016","journal-title":"Asian J. Pharm. Sci."},{"key":"10.1016\/j.bcp.2023.115699_b0195","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1038\/nmat4482","article-title":"A three-dimensional engineered tumour for spatial snapshot analysis of cell metabolism and phenotype in hypoxic gradients","volume":"15","author":"Rodenhizer","year":"2016","journal-title":"Nat. Mater."}],"container-title":["Biochemical Pharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0006295223002903?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0006295223002903?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,13]],"date-time":"2025-09-13T13:46:36Z","timestamp":1757771196000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0006295223002903"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,9]]},"references-count":39,"alternative-id":["S0006295223002903"],"URL":"https:\/\/doi.org\/10.1016\/j.bcp.2023.115699","relation":{},"ISSN":["0006-2952"],"issn-type":[{"value":"0006-2952","type":"print"}],"subject":[],"published":{"date-parts":[[2023,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Verification of fasting-mimicking diet to assist monotherapy of human cancer-bearing models","name":"articletitle","label":"Article Title"},{"value":"Biochemical Pharmacology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.bcp.2023.115699","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"115699"}}